chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Neck on left side became extremely painful and sore and could turn my head didnt sleep the first night and had a slight headache. Everything was fine within 2 days. Like nothing happened. On Day 9 experianced a flash of light out of left eye and a floating blob that came and went throughout the day. Saw Dr and he said this is typical of the aging process.  Dont know if it was related just weird it happened now. Arm was sore for 2 Days but nothing major. Other than that i felt fine.
Right arm red, swollen, hot to touch. 04/10/2011 Area became larger and symptoms above continued. 04/11/2011 Area approximately 3"x5" with redness, swelling, warmth still present.  Referred to primary MD for evaluation.
Muscular pain developed two days after the shot, limited range of motion in my left arm for the next ten days. My inner left bicep still has lingering discomfort
Information has been received from a consumer concerning her son who in 1996 was vaccinated with a dose of varicella vaccine. On 08/23/2001, it was reported that the pt had several "bug bite-like rashes" and he had a fever of 103 deg. F last week. The pt's mother believes he may have chicken pox. The pt did not seek medical attention. Additional info has been requested.
Red rash  at injection site developed ~8 days after vaccination. Approximately 3" diameter. No itching or pain, no systemic symptoms.
arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little sore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm was a little sore). At the time of the report, PAIN IN EXTREMITY (arm was a little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. Concomitant medications not reported. Med Info Agent: Staff Customer called to report that him and his wife had received the first dose of the Moderna COVID-19 Vaccine on Monday (26APR2021). Customer states his arm was a little sore but his wife was ok. But that night, customer reports that his wife woke up in the middle of the night and was not feeling good. Customer reports that shoulder of the injection site down to the elbows and wrist became sore. The next day, 27APR2021, customer states that his wife had said that it felt like she had an electrical current running through her head which felt like her whole brain was being shorted out.  No additional information could be obtained regarding the husband's case.; Sender's Comments:  MOD-2021-100555:Wife's case
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 30-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.  Concomitant medication was not provided.
Started with pain at injection site, then pain throughout back, neck, muscle aches in legs, abdomen, chills, fever, loss of appetite, then sweats persisting through October 5.  The injection site became red and swollen and remained tender.
Received 2nd COVID19 vaccine on 10/22/21 on left arm  Appearance of rash at onset: on the forehead in the evening, the following day noticed rash on hands. Rash was itchy.  Rash seemed to improve after a few a days last week, then 3 days ago rash seemed to spread to head, face, neck , trunk, shoulders, arms. Rash became very itchy - painful. Only slept 2 hrs over 3 days ago. No rash or itching on lower body   He previously had COVID 19 vaccines in in June and July 2021 - no symptoms  COIVD 19 Pfizer 9/30/31 - no symptoms  and 10/22/21 had a low grade fever 99-100F  rash the following day  Vaccines at in  Left deltoid   Discomfort associated with rash: painful and pruritic  - worse at night  Associated symptoms: no associated symptoms - denies respiratory sx, swelling, GI upset    Any previous evaluation of rash? NO Any previous treatment? Benadryl last night, helped with sleep  Any contacts with similar rash? NO , lives with one roommate  Any identified precipitant? possibly  Any new exposures: soaps, lotions, laundry detergents, foods,  medications, plants, insects or animals? only Pfizer COVID19 vaccine Recent travel?  NO
1/2/22 Pt presented to ED w/complaints of weakness, fatigue, cough and SOB. She was found to have a pleural effusion and pneumonia on CXR. She was positive for SARS CoV-2 and anemic. She was admitted to the hospital on oxygen at 2L nasal canula , IV ATB and gentle diuresis. Her hgb dropped and she was given 1 uPRBC's. She was found to decreased LOC, hypoxic after O2 dislodged. She had progressive decline and family transitioned her to comfort care. She died on 1/5/2022
She experienced sweats and chills; She experienced sweats and chills; She states she began having a racing heart moments after the injection.; it continued with chest soreness; This is a spontaneous report received from a contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 03Feb2021 1st Dose, Single for Covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient had the first dose of the Pfizer Covid 19 vaccine (last Wednesday) on 03Feb2021.  On the same date, the patient began having a racing heart moments after the injection, it continued with chest soreness. On 04Feb2021, she experienced sweats and chills. The patient went back to work and it continued with chest soreness. She experienced sweats and chills the next morning on 04Feb2021 and the racing heart continued the next day. On 05Feb2021 (Friday) it was a little better but continued. Later she felt more normal and herself. She did not know what kind of reaction it was. "She asked how many people in the clinical trial reported a fast heartbeat". The patient underwent lab tests and procedures which included heart rate: racing on 03Feb2021. The outcome of the events was resolving.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
I fainted( the day after 1st dose); When I regained conscious I started to feel numbness and tingling in both arms and hands and few minutes later on both legs and feet.; My blood pressure was 89; When I regained conscious I started to feel numbness and tingling in both arms and hands and few minutes later on both legs and feet.; pain in joint; I have been feeling burn; This is a spontaneous report from a contactable consumer. A 52-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot Number: EN6204) via an unspecified route of administration, administered on left arm on 19Mar2021 08:45 (Batch/Lot Number: EN6204) and second dose via an unspecified route of administration, administered on left arm on 09Apr2021 09:15 (Lot Number: EP7533) as single dose, for covid-19 immunization. The patient Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient concomitant medications were not reported. On 20Mar2021 02:00 PM, the patient fainted after the 1st dose. Her blood pressure was 89. When she regained conscious, she started to feel numbness and tingling in both arms and hands and few minutes later on both legs and feet. Since then, she had been feeling burn and tingling in her hands and feet. Some pain in her joint. The paramedic asked her to walk and then It went away on that moment. The patient underwent lab tests and procedures which included blood pressure measurement was 89. The patient did not receive any treatment for the events. The outcome of the events was reported was recovered /Recovered with lasting effects.   Information about Lot/Batch number is obtained. Additional information has been requested
Covid pfizer 12yr + vaccine given instead of the covid pfizer 5-11yr vaccine.
Fatigue, headache, myalgia, nausea, chills, decreased appetite within 24 hours of vaccine administration.
pain in the arm, beginning from day 2 until day 5, then better from day 7 severe itch around the plpace of the injection, then skin rash and swelling/hardened tissue, increasingly painful (at first only when touched, then always)
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided. From 09-MAR-2016 to 01-APR-2016, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) lot # K007979 with expiration date 03-JUN-2016, lot # K015970 with expiration date 23-SEP-2016 and lot # L017144 with expiration date 13-MAY-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 7.4 degrees Fahrenheit for 12 hours and 40 minutes. This is one of several reports received from the same reporter. Additional information has been requested.
Vaccine given on 9/29/22. On 10/18/22 she went to the ER due to arm neck and shoulder pain. She then followed up on 10/28/22 and was referred to ortho. With ortho she has had EMG and MRI. She was diagnosed with brachial neuritis. She is doing home therapy.
Headache, Myalgia, Fever, Swelling L arm, leg, foot Narrative:
itchy palms w/in 1/2hr of vax;progressed to gen urticaria;tx w/antihistamines;has recurrences still the appearance of 1-2 hives;significant allergic hx;
This spontaneous report as received from a pharmacist refers to a female patient of unknown age with no known drug reactions/allergies. On 17-OCT-2013 or 18-OCT-2013 the patient was vaccinated with a dose of ZOSTAVAX, via for shingles vaccine int he patient's unspecified physician's office. In October 2013 the patient had an adverse event involving injection site on an unspecified date. Patient described the injection site as of 21-OCT-2013 (reported as "today"), as having a red, swollen area the size of 3 inches by 5 inches and warm to touch. Patient did not state that she was experiencing any pain. Patient was currently prescribed ENTOCORT, pantoprazole and an unspecified thyroid medicine. The patient had not sought medical attention. No treatment was given. The event outcome was reported as not recovered. Additional information has been requested.
Vaccine 3-18-2011; onset of severe abd pain 3-20-2011. ER 3-21-2011 and admission to hospital for poss. Crohn's exacerbation. Dr did not find evidence of Crohn's exacerbation.
Pt complained of myalagia, aches and pain all over as well as a fever of 102.2. Pt continues to have fever, aches and pain.
Initial misuse report received from health care professional on 15 May 2013. Only DTaP-IPV portion of PENTACEL was administered to a 4-month-old patient. No adverse event was reported. List of documents held by sender: none.
Afternoon after receiving vaccination, developed diarrhea and nausea, feeling faint and lightheaded, jittery, clammy. Symptoms have stayed the same since receiving vaccine.
This spontaneous report as received from a certified medical assistant (CMA) refers to a 13 years old female patient who on 15-AUG-2012, was vaccinated with a first dose of GARDASIL (dose, and route not reported). No other co-suspects were reported. Concomitant medications included: hepatitis A virus vaccine (unspecified) (manufacturer unspecified) (dose, and route not reported). The CMA informed that on 15-AUG-2012 the patient got her first dose of GARDASIL (dose, and route not reported) and fainted. At the time of the report, the patient's outcome of fainted was unknown. Additional information has been requested.
ADVERSE EVENT - BELLS PALSY- RIGHT TREATMENT - DELAYED TO JUST OVER 72 HOUR FROM ONSET - EVENING 2/23/21 PREDNISONE 60 MG ORALLY DAILY FOR 7 DAYS & VALCYCLOVIR 1 G TID FOR 7 DAYS NEAR TOTAL RECOVERY BY 3/8/21
PATIENT PRESENTED 2 DAYS AFTER VACCINATION WITH REDNESS AND RASH NOTED ON UPPER R DELTOID REGION AND C/O OF AREA BEING VERY ITCHY OVER LAST 2 DAYS.
This spontaneous report as received from a registered pharmacist refers to a 50 year old female patient. On 27-DEC-2013 the patient was vaccinated subcutaneously with a dose of 0.65 ml ZOSTAVAX (lot # J008432, expired date: 11-OCT-2014) in the left arm. 4-5 days after vaccinations of ZOSTAVAX, approximately on 31-DEC-2013 the patient broke out with shingles. The patient had pain on the right side and underneath the right breast area and then a rash developed around the right breast and right side. Unspecified antiviral and unspecified topical compounded pain cream was given for the event. There was no lab diagnostics studied performed. At the time of reporting, the outcome of the event was unknown. The patient sought medical attention by visiting to unspecified physician and pharmacist. This is one of the several reports from the same reporter.  Additional information has been requested.
Nausea, diarrhea, aches, fever 100. Weakness light headed, chills.
Redness, swelling/warmth to area of injection, Temp 98.8, also, noted tenderness. Time frame=2 days post MMR.
Administration Error (Invalid Dose); This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Administration Error (Invalid Dose)) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Administration Error (Invalid Dose)). At the time of the report, INCORRECT DOSE ADMINISTERED (Administration Error (Invalid Dose)) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Treatment information not provided.
Pt c./o dizziness after 2nd Moderna vaccine. She also c/o "menthol feeling" in her throat around 1045. She appeared anxious, taping fingernails on desk. She kept clearing her throat. I had a RN and ERT with me monitoring patient, we kept asking her if she could breathe and she stated "yes, this will pass",  alert and oriented X 3. She refused to let us lay her down in supine position. BP 128/82. Around 1116 the throat clearing increased and patient no longer responding to questions and refused to talk. 1117 gave 1st dose of Epinephrine via autoinjector, applied oxygen via non-rebreather mask and gave 50 mg of Benadryl IM, ERT called EMSA to take patient to emergency department, total of 4 doses of epinephrine given via autoinjector prior to EMSA arrival. RN started 22G IV, patency checked to left Clinic around 1125. Pt oxygen saturations between 92-98% the entire time, heart rhythm regular and breath sounds normal throughout lung lobes, 1138 EMSA arrived, BP 145/114, pt remains on non rebreather mask, EMSA department with patient around 1140
Warm; swollen from shoulder to elbow; arm got sore again; got severe itching; I had sore arm for day or so; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (I had sore arm for day or so), PAIN IN EXTREMITY (arm got sore again), PRURITUS (got severe itching), INJECTION SITE WARMTH (Warm) and SWELLING (swollen from shoulder to elbow) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), GABAPENTIN, MIRABEGRON (MYRBETRIQ), CHLORDIAZEPOXIDE, CLIDINIUM BROMIDE (LIBRAX [CHLORDIAZEPOXIDE;CLIDINIUM BROMIDE]) and BUSPIRONE HYDROCHLORIDE (BUSPAR) for an unknown indication.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (I had sore arm for day or so). On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm got sore again) and PRURITUS (got severe itching). On 28-Feb-2021, the patient experienced INJECTION SITE WARMTH (Warm) and SWELLING (swollen from shoulder to elbow). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (I had sore arm for day or so), PAIN IN EXTREMITY (arm got sore again), PRURITUS (got severe itching), INJECTION SITE WARMTH (Warm) and SWELLING (swollen from shoulder to elbow) outcome was unknown.
Extreme muscle soreness, lasting greater than 2 weeks.  Still present today 09/02/2010.  Limits mobility of arm.  Initially a very sharp sudden pain, depending on movement.  Now more of a dull pain, but still related to certain muscle movements.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 46-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Oct2022 as DOSE 4 (BOOSTER), SINGLE (lot number: GJ6796) at the age of 46 years old, administered in the left arm for COVID-19 immunization; Covid-19 vaccine (COVID-19 VACCINE), as DOSE 1, SINGLE (batch/lot number: unknown), as DOSE 2, SINGLE (batch/lot number: unknown) and as DOSE 3 (BOOSTER), SINGLE (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19." The patient underwent the following laboratory tests and procedures: COVID-19 test (SARS-CoV-2 test): Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of Drug ineffective, Covid-19 which included Paxlovid treatment from 29Dec2022 to 02Jan2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route of administration not specified) for the long-term prevention of shingles and zoster-related conditions. Subsequent to the patient's zoster vaccine live (ZOSTAVAX) inoculation, on an unspecified date, the patient experienced shingles and was treated by a healthcare provider. As a direct and proximate result of patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event was considered to be not recovered. The reporter considered shingles to be related to Zoster Vaccine Live (ZOSTAVAX).
Three weeks after my vaccine shot I was dx with bilateral pulmonary embolism; This is a spontaneous report from a contactable consumer (patient). A 70-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 13Feb2021 (Batch/Lot Number: EN6201) as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. None Known allergies. Patient was not pregnant. No other vaccine in four weeks. Historical vaccine included BNT162B2 (product=COVID 19, brand=Pfizer, lot number=EL9261) first dose administered in Left arm on 23Jan2021 01:15 PM. The patient experienced three weeks after her vaccine shot she was dx with bilateral pulmonary embolism on 16Mar2021 06:00 AM with outcome of not recovered. The event resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The patient was hospitalized for the event for 4 days.  The patient's hospitalization was prolonged as a result of this event. The patient underwent lab tests which included Nasal Swab (sars-cov-2 test): negative on 17Mar2021. No covid prior vaccination. The treatment received included anti-coagulative therapy.
Fever 100.9, chills. Generalized body aches, severe edema, sensitivity to touch.
one week after receiving the 2nd vaccine dose, I felt fatigued when climbing  a flight of stairs for two days. Ten days after receiving the 2nd dose, I felt extreme pain in my lower back, pelvic area and vaginal area and pressure in vaginal area similar to when I was previously pregnant many years ago. The pain was so intense that I went to the ED and felt I had vaginal prolapse. Upon examination and labs at the ED, they informed me to follow up with my gynecologist and primary care physician for the intense pain and also one of my labs (lipase was elevated 870). The intense pain continued for three days. I used a heating pad to manage the pain. My PCP reordered the labs the following week and they returned to normal. My PCP and gynecologist ordered an abdominal and transvaginal US the following week. All results were negative. I believe this episode was a result of the vaccine.
Pain, fever, urgent care, palpitations, pain in my chest and back (left side), piano in my whole body, rash in my legs and thighs.